| 英文名称 | 中文名称 | CAS |
|---|---|---|
| BI 2536;BI-2536 | 4-[[(7R)-8-环戊基-7-乙基-5,6,7,8-四氢-5-甲基-6-氧代-2-喋啶基]氨基]-3-甲氧基-N-(1-甲基-4-哌啶基)苯甲酰胺;4-[[(7R)-8-环戊基-7-乙基-5,6,7,8-四氢-5-甲基-6-氧代-2-戊啶基]氨基]-3-甲氧基-N-(1-甲基-4-哌啶基)-苯甲酰胺 | 755038-02-9 |
| BI-6727 | N-[反式-4-[4-(环丙基甲基)-1-哌嗪基]环己基]-4-[[(7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺 | 755038-65-4 |
| RVX-208 | 2-[3,5-二甲基-4-(2-羟基乙氧基)苯基]-5,7-二甲氧基喹唑啉-4(3H)-酮;2-(4-(2-羟基乙氧基)-3,5-二甲基苯基)-5,7-二甲氧基喹唑啉-4(3H)-酮;2-(4-(2-羟基乙氧基)-3,5-二甲基苯基)-5,7-二甲氧基-4(3H)-酮 | 1044870-39-4 |
| BGB-283 | BGB-TG-P1 | 1446090-77-2 |
| HDM-201 | NVP-HDM201 | 1448867-41-1 |
| GDC-0981 | (S)-1-[4-[[2-(2-氨基嘧啶-5-基)-7-甲基-4-(吗啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基]哌嗪-1-基]-2-羟基丙-1-酮 | 1032754-93-0 |
| TAK-441 | TAK-441 | 1186231-83-3 |
| PKC-412 | 米哚妥林 | 120685-11-2 |
| TAS-116 | TAS-116 | 1260533-36-5 |
| RG-120 | 艾伏尼布 | 1448347-49-6 |
| AZD-3965 | AZD3965 | 1448671-31-5 |
| Pyridoclax | Pyridoclax | 1651890-44-6 |
| MS-275 | 恩替诺特 | 209783-80-2 |
| Miriplatin | 米铂水合物 | 250159-48-9 |
| H-1152 | H-1152;H 1152;H1152 | 451462-58-1 |
| Benzamide Riboside | 苯甲酰胺核苷 | 138385-29-2 |
| YM-155 | 4,9-二氢-1-(2-甲氧基乙基)-2-甲基-4,9-二氧代-3-(2-吡嗪甲基)-1H-萘并[2,3-D]咪唑溴化物 | 781661-94-7 |
| CFI-400945 fumarate | CFI-400945 | 1338806-73-7 |
| FK228 | 罗米地辛 | 128517-07-7 |
| EPZ-5676,Pinometostat | EPZ 5676;9-[5-脱氧-5-[[顺式-3-[2-[6-叔丁基-1H-苯并咪唑-2-基]乙基]环丁基](1-甲基乙基)氨基]-BETA-D-呋喃核糖基]-9H-嘌呤-6-胺 | 1380288-87-8 |
| BMS-906024 | BMS-906024 | 1401066-79-2 |
| BYL-719 | (2S)-N1-[4-甲基-5-[2-(2,2,2-三氟-1,1-二甲基乙基)-4-吡啶基]-2-噻唑基]-1,2-吡咯烷二甲酰胺;(2S)-N1-[4-甲基-5-[2-(2,2,2-三氟-1,1-二甲基乙基)-4-吡啶]-2-噻唑]-1,2-吡咯烷二羧酰胺 | 1217486-61-7 |
| ARQ-197 | (3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 | 905854-02-6 |
| ARQ-087 | 德拉赞替尼 | 1234356-69-4 |
| INCB 018424(Ruxolitinib Phosphate);INCB 018424 (phosphate);INCB018424 (phosphate) | (BETAR)-BETA-环戊基-4-(7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-丙腈磷酸盐;(BETAR)-BETA-环戊基-4-(7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-丙腈磷酸;卢索替尼磷酸盐;(3R)-3 -环戊基-3-4-[(7H吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑基]丙腈磷酸;磷酸鲁索利替尼;(BETAR)-BETA-环戊基-4-(7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-丙腈磷酸盐(鲁索利替尼磷酸盐);鲁索利替尼磷酸盐 | 1092939-17-7 |
| GDC-0810 | (E)-3-(4-((E)-2-(2-CHLORO-4-FLUOROPHENYL)-1-(1H-INDAZOL-5-YL)BUT-1-EN-1-YL)PHENYL)ACRYLIC ACID | 1365888-06-7 |
| PF-00299804 | PF299804;(E)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-METHOXYQUINAZOLIN-6-YL)-4-(PIPERIDIN-1-YL)BUT-2-ENAMIDE;(2E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基-6-喹唑啉基]-4-(1-哌啶基)-2-丁烯酰胺;PF299804(EGFR抑制剂);PF299804;DACOMITINIB;达克替尼;PF299804,达克替尼;EGFR抑制剂;达克米替尼 | 1110813-31-4 |
| FK866 (APO866);FK866 (APO866, Daporinad) | (2E)-N-[4-(1-苯甲酰基-4-哌啶基)丁基]-3-(3-吡啶基)-2-丙烯酰胺;达珀利奈 | 658084-64-1 |
| Panobinostat | 帕比司他;2-丙烯酰胺, N-羟基-3-[4-[[[2-(2-甲基-1H-吲哚-3-基)乙基]氨基]甲基]苯基]-, (2E)-;帕比司他工艺及其杂质 | 404950-80-7 |
| MLN2238(iaxzomib);MLN2238(Ixazomib) | B-[(1R)-1-[[2-[(2,5-二氯苯甲酰基)氨基]乙酰基]氨基]-3-甲基丁基]硼酸;埃沙佐米;艾沙佐米;IAXZOMIB阿西咗眯;阿西佐米;阿西咗眯 | 1072833-77-2 |
| ABL-001 | ABL-001 | 1492952-76-7 |
| GDC-0994 | GDC-0994 | 1453848-26-4 |
| PF-06459988 | 化合物PF-06459988 | 1428774-45-1 |
| Nifedipine | 利心平 ;硝苯吡啶 ;硝苯啶 ;硝基地平 ;1,4-二氢-2,6-二甲基-4-(2-硝基苯基)-3,5-吡啶二羧酸二甲酯;心痛定;硝苯地平;硝苯地平(心痛定 | 21829-25-4 |
| RS-102895hydrochloride | 1'-[2-[4-(三氟甲基)苯基]乙基]-螺[4H-3,1-苯并恶嗪-4,4'-哌啶]-2(1H)-酮;RS 102895 盐酸盐 | 300815-41-2 |
| EPZ-005687 | EPZ005687 | 1396772-26-1 |
| GKT-137831 | 2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 | 1218942-37-0 |
| ZSTK-474 | 2-(2-二氟甲基苯并咪唑-1-基)-4,6-二吗啉基-1,3,5-三嗪;ZSTK474 BASE | 475110-96-4 |
| SW-044248 | SW-044248 | 522650-83-5 |
| KU-55933 | 2-吗啉-4-基-6-噻蒽-1-基吡喃-4-酮 | 587871-26-9 |
| ABT888_Freebase | 2-[(2R)-2-甲基-2-吡咯烷基]-1H-苯并咪唑-7-甲酰胺;2-[(2R)-2-甲基-2-吡咯烷基]-1H-苯并咪唑-4-甲酰胺;VELIPARIBABT-888;API VELIPARIB;2-[(2R)-2-甲基-2-吡咯烷基]-1H-苯并咪唑-7-甲酰胺,奥拉帕尼中间体;(R)-2-(2-甲基-2-吡咯烷基)-1H-苯并咪唑-4-甲酰胺 (VELIPARIB);(S)-2-(2-(2-甲基)吡咯烷基)-1H-苯并咪唑-4-甲酰胺;ABT 888(维利帕尼) | 912444-00-9 |
| TAE-226 | 2-[[5-氯-2-[[2-甲氧基-4-(4-吗啉基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯甲酰胺 | 761437-28-9 |
| MK-1775 | 2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基)-6-(4-(4-甲基哌嗪-1-基)苯基氨基)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮 | 955365-80-7 |
| GDC-0449 | 2-氯-N-[4-氯-3-(2-吡啶基)苯基]-4-(甲磺酰基)苯甲酰胺;维莫地尼;2-氯-N-(4-氯-3-(吡啶-2-基)苯基)-4-(甲基磺酰基)苯甲酰胺;维莫德吉 | 879085-55-9 |
| CP-690550 | 3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈;(3R,4R)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-基氨基)-BETA-氧代-1-哌啶丙腈;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-;1-哌啶丙腈, 4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-基氨基)-Β-氧代-, (3R,4R)-;他索替尼;CP690550<3-<<3R,4R>-4-甲基 | 477600-75-2 |
| MK-8033 | 3-(1-甲基-1H-吡唑-4-基)-5-氧代-N-(2-吡啶甲基)-5H-苯并[4,5]环己烯并[1,2-B]吡啶-7-甲磺酰胺 | 1001917-37-8 |
| BGJ-398 | 3-(2,6-二氯-3,5-二甲氧基苯基)-1-[6-[[4-(4-乙基哌嗪-1-基)苯基]氨基]嘧啶-4-基]-1-甲基脲 | 872511-34-7 |
| WDR5-0103 | WDR5 0103 | 890190-22-4 |
| AZD-2014 | 3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺 | 1009298-59-2 |
| Pomalidomide | 3-氨基-N-(2,6-二氧代-3-哌啶基)邻苯二甲酰亚胺;泊马度胺;4-氨基-2-(2,6-二氧哌啶-3-基)异吲哚啉-1,3-二酮;泊马度胺-D4;4-氨基-2-(2,6-二氧代哌啶-3-基)异吲哚-1,3-二酮 | 19171-19-8 |
| E-7080 | 4-[3-氯-4-(环丙基氨基羰基)氨基苯氧基]-7-甲氧基-6-喹啉甲酰胺;LENVATINIB;乐伐替尼;LENVATINIB E7080 乐伐替尼;乐伐替尼、E7080;4-[3-氯-4-(环丙基氨基羰基)氨基苯氧基]-7-甲氧基-6-喹啉甲酰胺 乐伐替尼;乐法替尼;乐伐替尼杂质(A-D) | 417716-92-8 |
| GSK-2194069 | 1332331-08-4 | 1332331-08-4 |
| ABT-737 | 4-[4-[(4'-氯[1,1'-联苯]-2-基)甲基]-1-哌嗪基]-N-[[4-[[(1R)-3-(二甲基氨基)-1-[(苯硫基)甲基]丙基]氨基]-3-硝基苯基]磺酰基]苯甲酰胺;4-[4-[(4'-氯-联苯-2-基)甲基]哌嗪-1-基]-N-[[4-[[(1R)-3-(二甲胺基)-1-[(苯基硫基)甲基]丙基]氨基]-3-硝基苯基]磺酰基]苯甲酰胺 | 852808-04-9 |
| ABT-263 | 生根粉263;N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶]氨基]-1,2,3,4-四氢萘-1,4-脒-9-基]-2-氧代乙基]乙酰胺;生根粉263(不确定) | 923564-51-6 |
| TKI-258 | 4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮;TKI258; CHIR-258;多韦替尼碱 | 405169-16-6 |
| Risperidone | 利培酮;3-[2-[4-(6-氟-1,2-苯并异噁唑-3-基)-1-哌啶]乙基]-6,7,8,9-四氢-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮;3-[2-[4-(6-氟-1,2-苯并异噁唑-3-基)-1-哌啶基]乙基]-6,7,8,9-四氢-2-甲基-4H-吡啶并[1,2-α]嘧啶-4-酮;瑞司哌酮;瑞斯哌东;利哌利酮,利司环酮,利司培酮;3-[2-[4-(6-氟-1,2-苯并异噁唑-3-基)哌啶-1-基]乙基]-6,7,8,9-四氢-2-甲基-4H-吡啶并[1,2-Α]嘧啶-4-酮;利哌利酮 | 106266-06-2 |
| Formestane | 4-羟基-睾酮 ;福美斯坦 ;福美坦 ;福美司坦;4-羟基雄甾烷-4-烯-3,17-二酮;4-雄烯-4-醇-3,17-二酮;芳香化酶(抗原);芳香化酶/(细胞色素P450)(P450)(抗体) | 566-48-3 |
| Temozolomide | 3,4-二氢-3-甲基-4-氧代咪唑并[5,1-d]-1,2,3,5-四嗪-8-甲酰胺;4-甲基-5-氧代-2,3,4,6,8-五氮杂双环[4.3.0]壬-2,7,9-三烯-9-甲酰胺;替莫唑胺;3,4-二氢-3-甲基-4-氧咪唑并[5,1-D]-1,2,3,5-四唑-8-羧酰胺;替莫唑铵;替莫唑胺98%;替莫唑胺(蒂清);TEMODAR TEMOZOLOMIDE | 85622-93-1 |
| INK-128 | 3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 | 1224844-38-5 |
| AZD-1480 | 5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 | 935666-88-9 |
| BIIB-024;MLN 2480;MLN2480 (BIIB-024) | 6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶基]氨基]羰基]-2-噻唑基]乙基]-4-嘧啶甲酰胺 | 1096708-71-2 |
| GSK-2606414 | GSK2606414;7-甲基-5-[1-[[3-(三氟甲基)苯基]乙酰基]-2,3-二氢-1H-吲哚-5-基]-7H-吡咯并[2,3-D]嘧啶-4-胺 | 1337531-36-8 |
| CCT-251921 | CCT251921 | 1607837-31-9 |
| CH-5424802 | 9-乙基-6,11-二氢-6,6-二甲基-8-[4-(4-吗啉基)-1-哌啶基]-11-氧代-5H-苯并[B]咔唑-3-甲腈;9-ETHYL-6,6-DIMETHYL-8-(4-MORPHOLINOPIPERIDIN-1-YL)-11-OXO-6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE-3-CARBONITRILE;艾乐替尼ALECTINIB (CH5424802);艾乐替尼;9-乙基-6,6-二甲基-8-(4-吗啉哌啶-1-基)-11-氧代-6,11-二氢-5H-苯并[B]咔唑- | 1256580-46-7 |
| A-1210477 | A-1210477 | 1668553-26-1 |
| ABC294640 | 3-(4-氯苯基)-N-(4-吡啶基甲基)金刚烷-1-甲酰胺 | 915385-81-8 |
| ABT-199;ABT199,GDC0199;GDC 0199;GDC0199;GDC-0199;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-benzamide;Benzamide, 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl] | ABT-199 | 1257044-40-8 |
| Doxorubicin HCI | (8S-cis)-10-[(3-氨基-2,3,6-三去氧-a-L-来苏己吡喃基)-氧]-7,8,9,10-四氢-6,8,11-三羟基-8-羟基乙酰基-1-甲氧基-5,12-并四苯二酮盐酸盐;盐酸多柔比星;14-羟正定霉素 ;阿得里亚霉素 ;(8S-cis)-10-((3-氨基-2,3,6-三去氧-a-L-来苏己吡喃基)-氧)-7,8,9,10-四氢-6,8,11-三羟基-8-羟基乙酰基-1-甲氧基-5,12-并四苯二酮盐酸盐;阿霉素盐酸盐;亚德里亚霉素盐酸盐;盐酸阿霉素 | 25316-40-9 |
| AEE-788 | 6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺;AEE 788AEE-788 | 497839-62-0 |
| AG-120;AG-120 racemic;AG-120 Ivosidenib | 1-(4-氰基-2-吡啶基)-5-氧代-L-脯氨酰-2-(2-氯苯基)-N-(3,3-二氟环丁基)-N2-(5-氟-3-吡啶基)甘氨酰胺 | 1448346-63-1 |
| AGI-6780 | N-环丙基-4-(3-噻吩基)-3-[[[[3-(三氟甲基)苯基]氨基]羰基]氨基]-苯磺酰胺 | 1432660-47-3 |
| AZD 3463;AZD3463;AZD-3463 | N-[4-(4-氨基-1-哌啶基)-2-甲氧基苯基]-5-氯-4-(1H-吲哚-3-基)-2-嘧啶胺 | 1356962-20-3 |
| ALR-3456;ALR-3456 , MK-0731 | (2S)-4-(2,5-二氟苯基)-N-[(3R,4S)-3-氟-1-甲基-4-哌啶基]-2,5-二氢-2-羟基甲基-N-甲基-2-苯基-1H-吡咯-1-羧胺 | 845256-65-7 |
| Ap 23573;Ap23573;Ap-23573;Mk-8669 | 42-(二甲基亚膦酰)雷帕霉素 | 572924-54-0 |
| AP-26113 | 5-氯-N2-[4-[4-(二甲基氨基)-1-哌啶基]-2-甲氧基苯基]-N4-[2-(二甲基亚膦酰)苯基]-2,4-嘧啶二胺 | 1197953-54-0 |
| ARRY 142886;AZD 6244 | 5-[(4-溴-2-氯苯基)氨基]-4-氟-N-(2-羟基乙氧基)-1-甲基-1H-苯并咪唑-6-甲酰胺;5-[(4-溴-2-氯苯基)氨基]-4-氟-N-(2-羟基乙氧基)-1-甲基-1H-苯并[D]咪唑-6-甲酰胺;AZD6244; ARRY142886;3-氧杂-9-氮杂螺[5.5]十一烷盐酸盐;司美替尼-AZD6244;司美替尼;司美替尼(系统里没有) | 606143-52-6 |
| ARRY-380 | 6-[5-[[[2-(甲磺酰基)乙基]氨基] | 937263-43-9 |
| ARRY-424704, ARRY-704;AZD8330 | 2-(2-氟-4-碘苯氨基)-N-(2-羟基乙氧基)-1,5-二甲基-6-氧代-1,6-二氢吡啶-3-甲酰胺;AZD-83302-(2-氟-4-碘苯氨基)-N-(2-羟基乙氧基)-1,5-二甲基-6-氧代-1,6-二氢吡啶-3-甲酰胺 | 869357-68-6 |
| ASP-3026 | N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-N4-[2-[(1-甲基乙基)磺酰基]苯基]-1,3,5-三嗪-2,4-二胺 | 1097917-15-1 |
| ASP-2215;Gilteritinib | 吉列替尼 | 1254053-43-4 |
| Rapamycin | 雷帕霉素;雷帕霉素,99%;瑞帕霉素;西罗莫司(雷帕霉素);西罗莫司口服液;雷帕霉素/西罗莫司;雷帕酶素;西罗莫司 | 53123-88-9 |
| AZD 1208;AZD1208;AZD-1208; | (5Z)-5-[[2-[(3R)-3-氨基-1-哌啶基][1,1'-联苯]-3-基]亚甲基]-2,4-噻唑烷二酮 | 1204144-28-4 |
| AZD-0156 | AZD0156 | 1821428-35-6 |
| AZD-0530 | 塞卡替尼 | 379231-04-6 |
| AZD3514 | AZD3514 | 1240299-33-5 |
| AZD-4547 | AZD-4547 | 1035270-39-3 |
| AZD-5363 | 4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺 | 1143532-39-1 |
| AZD-5582 | AZD 5582 | 1258392-53-8 |
| AZD6738;AZD-6738 | AZD6738 | 1352226-88-0 |
| AZD-8055 | [5-[2,4-二((3S)-3-甲基吗啉-4-基)吡啶并[2,3-D]嘧啶-7-基]-2-甲氧基苯基]甲醇;CCG 168 | 1009298-09-2 |
| AZD8186;AZD 8186 | 8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 | 1627494-13-6 |
| b-AP15;NSC-687852 | b-AP15 | 1009817-63-3 |
| BAY 87-2243 | BAY87-2243 | 1227158-85-1 |
| BAY1125976; BAY 1125976; BAY-1125976. | CS-2913 | 1402608-02-9 |
| BAY1143572; BAY 1143572; BAY-1143572. | ATUVECICLIB RACEMATE (BAY-1143572 RACEMATE) | 1414943-88-6 |
| INC280;INCB028060;CapMatinib (INCB28060);CapMatinib | 2-氟-N-甲基-4-[7-[(喹啉-6-基)甲基]咪唑并[1,2-B]-[1,2,4]三嗪-2-基]苯甲酰胺;苯扎米特;INCB28060(苯扎米特) | 1029712-80-8 |
| BMS-863233 | XL413 (BMS-863233) | 1169562-71-3 |
| EMD-1214063 | 3-(1-(3-(5-((1-METHYLPIPERIDIN-4-YL)METHOXY)PYRIMIDIN-2-YL)BENZYL)-1,6-DIHYDRO-6-OXOPYRIDAZIN-3-YL)B;3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-哒嗪基]苯腈 | 1100598-32-0 |
| BGB 102;BGB102;BGB-102;JNJ 26483327;JNJ26483327;JNJ-26483327 | 17-溴-1,8,9,10,11,12,13,14-八氢-20-甲氧基-13-甲基-4,6-乙烯桥嘧啶并[4,5-B][6,1,12]苯并氧杂二氮杂环十五碳七烯 | 807640-87-5 |
| BGT-226 Free base | BGT226 | 915020-55-2 |
